Caxton Associates (UK)’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,821
Closed -$248K 841
2025
Q1
$248K Buy
+33,821
New +$248K 0.01% 670